Gilead Sciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Gilead Sciences Inc 's inventory turnover ratio, the ratio that measures Gilead Sciences Inc 's ability to manage its supply chain, sequentially decreased to 3.3 in the third quarter 2026, but it does not raise any concerns as Gilead Sciences Inc continue to execute well, and the inventory turnover ratio remains above the average. Gilead Sciences Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 111 days, from 109 days, in the Jun 30 2026 quarter.

Within Healthcare sector 116 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2026, to 1147, from total ranking in the second quarter 2026 at 1293.

GILD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Gilead Sciences Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GILD Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Inventory Growth	6.22 %	7.01 %	8.81 %	3.74 %	-4.49 %
Y / Y Cost of Sales Growth	0.13 %	5.2 %	-6.17 %	2.72 %	-0.32 %
Inventory Turnover Ratio (TTM)	3.3	3.35	3.36	3.49	3.5
GILD's Total Ranking	# 1147	# 1293	# 1147	# 1146	# 1165
Average inventory processing period	111	109	108	105	104
Seq. Inventory Growth	-2.92 %	2.04 %	7.89 %	-0.62 %	-2.19 %
Seq. Cost of Sales Growth	-0.51 %	9.27 %	-11.02 %	3.51 %	4.53 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 12
Healthcare Sector	# 117
Overall Market	# 1147

Inventory Turnover Ratio Statistics
High	Average	Low
5.75	2.7	1.16
(Dec 31 2018)		(March 31, 2007)

GILD Company Profile >> Back to GILD Efficiency Comparisons >> Compare GILD Inventory Turnover Ratio to its Competitors

Financial Statements
Gilead Sciences Inc 's Inventories	$ 1,896 Millions	Visit GILD's Balance sheet
Gilead Sciences Inc 's Cost of Revenues TTM	$ 6,219 Millions	Visit GILD's Income Statement
What are GILD's Sales?		Visit GILD's Sales by Segment

Other Inventory Turnover Ratios
Gilead Sciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
GILD's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for GILD's Competitors
Inventory Turnover Ratio for GILD's Suppliers
Inventory Turnover Ratio for GILD's Customers

You may also want to know
GILD's Sales Growth Rates	GILD's Pe Price to earnings ratio	GILD's Receivables Turnover Ratio	GILD's Stock Quote
GILD's Net Income Growth Rates	GILD's Ps Price to Sales ratio	GILD's Sales per Employee	GILD's Asset Turnover Ratio
GILD's Net Margin	GILD's Pb Price to Book ratio	GILD's Financial Strength Ratios	GILD's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Vanda Pharmaceuticals Inc	8.70	$ 14.704 Millions	$ 2 Millions
Phathom Pharmaceuticals Inc	7.76	$ 53.106 Millions	$ 7 Millions
Novavax inc	7.03	$ 90.533 Millions	$ 13 Millions
Carlisle Companies Incorporated	6.99	$ 3,406.400 Millions	$ 488 Millions
Caredx Inc	6.42	$ 111.106 Millions	$ 17 Millions
Edap Tms Sa	6.14	$ 60.833 Millions	$ 10 Millions
Transmedics Group Inc	5.70	$ 301.220 Millions	$ 53 Millions
Bristol myers Squibb Company	5.65	$ 15,389.000 Millions	$ 2,722 Millions
Avantor Inc	5.48	$ 4,539.200 Millions	$ 828 Millions
Tactile Systems Technology Inc	5.25	$ 82.718 Millions	$ 16 Millions
Integer Holdings Corporation	4.98	$ 1,376.268 Millions	$ 276 Millions
Ge Healthcare Technologies Inc	4.69	$ 11,372.000 Millions	$ 2,425 Millions
West Pharmaceutical Services Inc	4.69	$ 2,120.200 Millions	$ 452 Millions
Henry Schein Inc	4.63	$ 9,395.000 Millions	$ 2,031 Millions
Cryoport inc	4.60	$ 102.157 Millions	$ 22 Millions
Idexx Laboratories Inc	4.52	$ 1,743.379 Millions	$ 386 Millions
Medinotec Inc	4.28	$ 5.143 Millions	$ 1 Millions
3m Company	4.02	$ 15,267.000 Millions	$ 3,801 Millions
Novocure Limited	3.98	$ 166.721 Millions	$ 42 Millions
Incyte Corporation	3.79	$ 439.399 Millions	$ 116 Millions
Baxter International Inc	3.57	$ 8,117.000 Millions	$ 2,277 Millions
Bausch Health Companies Inc	3.54	$ 4,518.000 Millions	$ 1,276 Millions
Exelixis Inc	3.49	$ 93.324 Millions	$ 27 Millions
Abbvie Inc	3.40	$ 17,346.000 Millions	$ 5,108 Millions
Gilead Sciences Inc	3.30	$ 6,219.000 Millions	$ 1,884 Millions
Iovance Biotherapeutics inc	3.21	$ 177.232 Millions	$ 55 Millions
Teva Pharmaceutical Industries Limited	3.16	$ 8,011.000 Millions	$ 2,537 Millions
Msa Safety Inc	3.00	$ 1,063.235 Millions	$ 354 Millions
Mimedx Group Inc	2.98	$ 70.562 Millions	$ 24 Millions
Ligand Pharmaceuticals Incorporated	2.93	$ 34.495 Millions	$ 12 Millions

Date modified: 2026-10-31T17:28:36+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.